Jiangxi Bio Unit Wins China Nod for Veterinary Tetanus Antitoxin
() -- Jiangxi Institute of Biological Products' (HKG:6915) wholly owned subsidiary, Chifeng Bo-en Pharmaceutical, received an approval certificate from Chinese regulators for its veterinary tetanus antitoxin, according to a Friday Hong Kong bourse filing. The product is used to prevent and treat tetanus infections in a